Venus Concept Secures 510(k) Approval for Venue NOVA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
Should l Buy VERO?
FDA Clearance: Venus Concept has received 510(k) clearance from the U.S. FDA to market the Venus NOVA, a next-generation multi-application platform for non-invasive treatments.
Technology Integration: The Venus NOVA combines Adaptive Electrical Muscle Stimulation, Multi-Polar Radio Frequency with Pulsed Electromagnetic Fields, and Advanced VariPulse technology for comprehensive body contouring and skin treatments.
Treatment Benefits: The platform is designed to enhance muscle conditioning, skin treatments, and reduce wrinkles and cellulite.
Market Impact: This innovative technology aims to redefine non-invasive aesthetic treatments in the beauty and wellness industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VERO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VERO
About VERO
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

- Earnings Beat: Intuitive Surgical reported Q4 revenue of approximately $2.87 billion and adjusted earnings of $2.53 per share, both exceeding analyst expectations, driven by year-over-year growth in procedure volume and robotic system placements, leading to a rise in after-hours trading.
- Dividend Increase: Kinder Morgan topped Q4 revenue expectations with about $4.51 billion and adjusted earnings of $0.39 per share, while announcing a 2% quarterly dividend increase to $0.2925 per share, despite slightly lowering its 2026 earnings outlook, reflecting cautious sentiment amid ongoing energy market dynamics.
- Expansion Plans: USA Rare Earth announced plans to establish a high-capacity metal and alloy production plant in Lacq, France, capable of producing about 3,750 metric tons per year through its subsidiary Less Common Metals, aimed at strengthening transatlantic supply chains and boosting investor optimism.
- Market Volatility: Despite subdued overall market performance, small-cap benchmarks reached new highs, indicating sustained investor demand for risk assets against a backdrop of easing geopolitical tensions, which positively influenced the performance of certain tech stocks.
See More

- Voluntary Delisting Decision: Venus Concept announced its intention to voluntarily delist from Nasdaq and cease SEC reporting, with the board determining that ongoing compliance costs outweigh the benefits of remaining publicly listed, highlighting a focus on financial health.
- Financial Status Disclosure: As of September 30, 2025, the company reported inventories totaling $15.768 million and cash equivalents of $4.312 million, indicating liquidity management pressures that could impact future operations.
- Delisting Timeline: The company plans to file Form 25 with the SEC on January 30, 2026, with the last trading day expected on February 6, 2026, followed by a Form 15 filing on February 9, 2026, which will immediately suspend periodic reporting obligations, marking a significant step towards privatization.
- Management Statement: CEO Rajiv De Silva stated that this action is in the best interests of the company and its shareholders, indicating that the company will continue to work with Madryn Asset Management to support long-term financial success, reflecting strategic planning for future growth.
See More

- Netflix Earnings Highlight: Netflix reported Q4 earnings per share of $0.56, beating the consensus estimate of $0.55, with revenue of $12.05 billion exceeding expectations of $11.97 billion; however, shares fell 3%, reflecting market concerns over future guidance.
- Cautious Future Outlook: The company guided for Q1 earnings per share of $0.76 and revenue of approximately $12.16 billion, which is below analyst expectations, indicating a cautious sentiment that may impact investor confidence moving forward.
- Advertising Revenue Growth: Netflix anticipates continued growth in advertising revenue and plans to invest across content, advertising initiatives, and newer formats including live events, video podcasts, and games, aiming to enhance its competitive edge and attract more users.
- Market Reaction: Despite exceeding earnings expectations, Netflix's stock dropped 3% to $84.20, indicating investor concerns about the company's growth prospects, which could affect its position in the highly competitive streaming market.
See More

- Voluntary Delisting Decision: Venus Concept has announced its intention to voluntarily delist and deregister with the SEC, expecting to cease trading on Nasdaq by February 6, 2026, despite remaining compliant with Nasdaq's listing requirements, highlighting the company's focus on compliance costs.
- Stock Price Impact: Following the delisting announcement, Venus Concept's shares plummeted over 50% in pre-market trading, indicating a strong market reaction to the decision that could affect investor confidence and future financing capabilities.
- Shareholder Structure Change: Last week, Madryn Asset Management acquired a 91% stake in Venus Concept, signaling support for the company's turnaround plan while potentially influencing governance and strategic direction.
- Management Outlook: CEO Rajiv De Silva stated that reducing compliance costs will facilitate the execution of the turnaround plan, and despite the delisting challenges, the company will continue to collaborate with Madryn Asset Management to achieve long-term financial success.
See More

- Voluntary Delisting Decision: Venus Concept (VERO) has decided to voluntarily delist from the Nasdaq Capital Market, as the board determined that the costs of reporting outweigh the benefits of remaining listed, indicating a focus on cost management.
- Delisting Timeline: The company expects to file Form 25 around January 30, 2026, with the last trading day anticipated on or about February 6, 2026, which will impact investors' holding strategies and market liquidity.
- Suspension of SEC Reporting Obligations: Venus Concept plans to file Form 15 around February 9, 2026, which will immediately suspend its SEC reporting obligations, reducing compliance burdens but potentially affecting transparency and investor confidence.
- Stock Price Volatility: Following the delisting announcement, VERO shares fell 54% in premarket trading, reflecting market concerns about the company's future and negative investor sentiment regarding the delisting decision.
See More
- Strategic Shift: Venus Concept has announced its intention to voluntarily delist from Nasdaq and deregister its securities, aiming to reassess its capital market presence and long-term operational structure, which is expected to reduce compliance costs and enhance management's focus on operational execution.
- Delisting Process: The company plans to file Form 25 with the SEC, with the delisting expected to take effect 10 days after submission, thereby alleviating administrative burdens by suspending its reporting obligations under the Securities Exchange Act of 1934.
- Market Performance: Over the past year, VERO's stock has traded between $1.39 and $14.50, currently priced at $2.19 in pre-market trading, reflecting a 50.55% drop, indicating a negative market reaction to the delisting announcement.
- Global Market Reach: Venus Concept develops and markets minimally invasive and non-invasive aesthetic and hair restoration technologies in over 60 countries, and despite the delisting, it will continue to support its products through a global distribution network.
See More






